Share chart Bionomics Limited
Extended chart
Simple chart
About Bionomics Limited
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. more details| Industry | Biotechnology |
|---|---|
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | aud |
| Сайт | https://www.bionomics.com.au |
| Цена ао | 0.006 |
| Change price per day: | 0% (0.006) |
|---|---|
| Change price per week: | 0% (0.006) |
| Change price per month: | 0% (0.006) |
| Change price per 3 month: | 0% (0.006) |
| Change price per half year: | 0% (0.006) |
| Change price per year: | 0% (0.006) |
| Change price per 3 year: | -86.49% (0.0444) |
| Change price per 5 year: | -77.78% (0.027) |
| Change price per year to date: | 0% (0.006) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Dr. Errol B. De Souza Ph.D. | Exec. Chairman | 1953 (72 years) | |
| Mr. Adrian Hinton BEC, F.C.A. | Acting Chief Financial Officer | 1952 (73 years) | |
| Mr. Connor Bernstein M.Sc. | VP of Strategy & Corp. Devel. | 1988 (37 years) | |
| Prof. Paul Rolan D.C.P.S.A., F.F.P.M., F.R.A.C.P., M.B.B.S., M.D. | Consultant Chief Medical Officer of Clinical Neuroscience | ||
| Ms. Suzanne Irwin B.Com., FCIS | Company Sec. |
Address: Australia, Eastwood, 200 Greenhill Road - open in Google maps, open in Yandex maps
Website: https://www.bionomics.com.au
Website: https://www.bionomics.com.au
